Promotion Of CAD’s Economic Advantages Critiqued In J-NCI Editorial
This article was originally published in The Gray Sheet
Executive Summary
Favorable reimbursement for computer-aided detection technology may be responsible for widespread dissemination of the devices, despite inconclusive evidence that they increase breast cancer detection and recall rates, according to a J-NCI editorial
You may also be interested in...
CAD Firms Solidify Mammography Deals, Look To Lung Indication
R2 Technology and iCAD's agreements with imaging equipment players reflect a growing reliance on computer-aided detection for mammography screening
CAD Firms Solidify Mammography Deals, Look To Lung Indication
R2 Technology and iCAD's agreements with imaging equipment players reflect a growing reliance on computer-aided detection for mammography screening
MedPAC Draft Recommendations Aim To Control Imaging Proliferation
Favorable reimbursement for imaging services has contributed to inappropriate use, according to MedPAC commissioner Nicholas Wolter, MD, Deaconess Billings Clinic in Billings, Mont